HomeCSCI • TSE
add
COSCIENS Biopharma Inc
Previous close
$4.25
Day range
$4.12 - $4.35
Year range
$3.78 - $9.00
Market cap
15.46M CAD
Avg Volume
2.23K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.87M | 62,266.67% |
Operating expense | 5.79M | 27.50% |
Net income | -5.76M | -38.84% |
Net profit margin | -307.59 | 99.78% |
Earnings per share | — | — |
EBITDA | -4.36M | 3.39% |
Effective tax rate | 1.91% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.00M | -48.40% |
Total assets | 43.77M | 3.02% |
Total liabilities | 23.76M | 46.56% |
Total equity | 20.01M | — |
Shares outstanding | 3.12M | — |
Price to book | 0.66 | — |
Return on assets | -25.76% | — |
Return on capital | -48.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.76M | -38.84% |
Cash from operations | -7.78M | -129.88% |
Cash from investing | 83.00K | 930.00% |
Cash from financing | -188.00K | -469.70% |
Net change in cash | -7.81M | -127.58% |
Free cash flow | -6.81M | -226.68% |
About
Founded
1990
Headquarters
Website
Employees
125
